La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys

Identifieur interne : 001D20 ( Main/Exploration ); précédent : 001D19; suivant : 001D21

Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys

Auteurs : Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada]

Source :

RBID : Pascal:10-0234566

Descripteurs français

English descriptors

Abstract

Behavioral investigations of selective and potent metabotropic glutamate receptor type 5 (mGluR5) antagonists in animal models suggest involvement of mGluR5 in compensatory mechanisms of the basal ganglia circuitry in Parkinson's disease and levodopa (L-Dopa) induced motor complications. This study investigated mGluR5 changes in MPTP lesioned monkeys. The effect of a chronic 1 month treatment with L-Dopa on mGluR5-specific binding and mRNA levels was investigated in MPTP monkeys killed 4 or 24 h after their last L-Dopa administration. [3H]ABP688 specific binding in the putamen was elevated in L-Dopa-treated MPTP monkeys killed 24 h but not 4 h after their last L-Dopa dose compared with vehicle-treated MPTP monkeys. Caudate nucleus [3H]ABP688-specific binding was elevated in both groups of L-Dopa treated compared with vehicle-treated MPTP monkeys. In contrast, caudate nucleus and putamen mGluR5 mRNA levels were elevated only in L-Dopa-treated MPTP monkeys killed 4 h after their last L-Dopa administration. MPTP monkeys killed 4 h after their last L-Dopa treatment showed higher caudate nucleus and putamen L-Dopa concentrations compared with those killed after 24 h. Hence, mGluR5 in the putamen are sensitive to presence of L-Dopa leading to a rapid decrease of [3H]ABP688-specific binding possibly involving a direct mGluR5/dopamine receptors interaction.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys</title>
<author>
<name sortKey="Ouattara, Bazoumana" sort="Ouattara, Bazoumana" uniqKey="Ouattara B" first="Bazoumana" last="Ouattara">Bazoumana Ouattara</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gasparini, Fabrizio" sort="Gasparini, Fabrizio" uniqKey="Gasparini F" first="Fabrizio" last="Gasparini">Fabrizio Gasparini</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neuroscience Research, Novartis Institutes for BioMedical Research</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gregoire, Laurent" sort="Gregoire, Laurent" uniqKey="Gregoire L" first="Laurent" last="Gregoire">Laurent Gregoire</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Samadi, Pershia" sort="Samadi, Pershia" uniqKey="Samadi P" first="Pershia" last="Samadi">Pershia Samadi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gomez Mancilla, Baltazar" sort="Gomez Mancilla, Baltazar" uniqKey="Gomez Mancilla B" first="Baltazar" last="Gomez-Mancilla">Baltazar Gomez-Mancilla</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neuroscience Research, Novartis Institutes for BioMedical Research</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">10-0234566</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0234566 INIST</idno>
<idno type="RBID">Pascal:10-0234566</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000440</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000837</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000361</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000361</idno>
<idno type="wicri:doubleKey">0022-3042:2010:Ouattara B:effect:of:l</idno>
<idno type="wicri:Area/Main/Merge">001E51</idno>
<idno type="wicri:Area/Main/Curation">001D20</idno>
<idno type="wicri:Area/Main/Exploration">001D20</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys</title>
<author>
<name sortKey="Ouattara, Bazoumana" sort="Ouattara, Bazoumana" uniqKey="Ouattara B" first="Bazoumana" last="Ouattara">Bazoumana Ouattara</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gasparini, Fabrizio" sort="Gasparini, Fabrizio" uniqKey="Gasparini F" first="Fabrizio" last="Gasparini">Fabrizio Gasparini</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neuroscience Research, Novartis Institutes for BioMedical Research</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gregoire, Laurent" sort="Gregoire, Laurent" uniqKey="Gregoire L" first="Laurent" last="Gregoire">Laurent Gregoire</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Samadi, Pershia" sort="Samadi, Pershia" uniqKey="Samadi P" first="Pershia" last="Samadi">Pershia Samadi</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Gomez Mancilla, Baltazar" sort="Gomez Mancilla, Baltazar" uniqKey="Gomez Mancilla B" first="Baltazar" last="Gomez-Mancilla">Baltazar Gomez-Mancilla</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Neuroscience Research, Novartis Institutes for BioMedical Research</s1>
<s2>Basel</s2>
<s3>CHE</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Molecular Endocrinology and Genomic Research Center, Laval University Medical Center (CHUL)</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Faculty of Pharmacy, Laval University</s1>
<s2>Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of neurochemistry</title>
<title level="j" type="abbreviated">J. neurochem.</title>
<idno type="ISSN">0022-3042</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of neurochemistry</title>
<title level="j" type="abbreviated">J. neurochem.</title>
<idno type="ISSN">0022-3042</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal model</term>
<term>Antagonist</term>
<term>Basal ganglion</term>
<term>Chronic</term>
<term>Complication</term>
<term>Encephalon</term>
<term>Glutamate receptor</term>
<term>Lesion</term>
<term>Levodopa</term>
<term>Metabotropic receptor</term>
<term>Monkey</term>
<term>Parkinson disease</term>
<term>Treatment</term>
<term>mglu5 glutamate receptor</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Récepteur métabotropique</term>
<term>Récepteur glutamate</term>
<term>Encéphale</term>
<term>Récepteur glutamate mglu5</term>
<term>Antagoniste</term>
<term>Modèle animal</term>
<term>Noyau gris central</term>
<term>Lévodopa</term>
<term>Maladie de Parkinson</term>
<term>Complication</term>
<term>Lésion</term>
<term>Chronique</term>
<term>Traitement</term>
<term>Singe</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Singe</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Behavioral investigations of selective and potent metabotropic glutamate receptor type 5 (mGluR5) antagonists in animal models suggest involvement of mGluR5 in compensatory mechanisms of the basal ganglia circuitry in Parkinson's disease and levodopa (
<sub>L</sub>
-Dopa) induced motor complications. This study investigated mGluR5 changes in MPTP lesioned monkeys. The effect of a chronic 1 month treatment with
<sub>L</sub>
-Dopa on mGluR5-specific binding and mRNA levels was investigated in MPTP monkeys killed 4 or 24 h after their last
<sub>L</sub>
-Dopa administration. [
<sup>3</sup>
H]ABP688 specific binding in the putamen was elevated in
<sub>L</sub>
-Dopa-treated MPTP monkeys killed 24 h but not 4 h after their last
<sub>L</sub>
-Dopa dose compared with vehicle-treated MPTP monkeys. Caudate nucleus [
<sup>3</sup>
H]ABP688-specific binding was elevated in both groups of
<sub>L</sub>
-Dopa treated compared with vehicle-treated MPTP monkeys. In contrast, caudate nucleus and putamen mGluR5 mRNA levels were elevated only in
<sub>L</sub>
-Dopa-treated MPTP monkeys killed 4 h after their last
<sub>L</sub>
-Dopa administration. MPTP monkeys killed 4 h after their last
<sub>L</sub>
-Dopa treatment showed higher caudate nucleus and putamen
<sub>L</sub>
-Dopa concentrations compared with those killed after 24 h. Hence, mGluR5 in the putamen are sensitive to presence of
<sub>L</sub>
-Dopa leading to a rapid decrease of [
<sup>3</sup>
H]ABP688-specific binding possibly involving a direct mGluR5/dopamine receptors interaction.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>Suisse</li>
</country>
</list>
<tree>
<country name="Canada">
<noRegion>
<name sortKey="Ouattara, Bazoumana" sort="Ouattara, Bazoumana" uniqKey="Ouattara B" first="Bazoumana" last="Ouattara">Bazoumana Ouattara</name>
</noRegion>
<name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<name sortKey="Di Paolo, Therese" sort="Di Paolo, Therese" uniqKey="Di Paolo T" first="Thérèse" last="Di Paolo">Thérèse Di Paolo</name>
<name sortKey="Gregoire, Laurent" sort="Gregoire, Laurent" uniqKey="Gregoire L" first="Laurent" last="Gregoire">Laurent Gregoire</name>
<name sortKey="Gregoire, Laurent" sort="Gregoire, Laurent" uniqKey="Gregoire L" first="Laurent" last="Gregoire">Laurent Gregoire</name>
<name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<name sortKey="Morissette, Marc" sort="Morissette, Marc" uniqKey="Morissette M" first="Marc" last="Morissette">Marc Morissette</name>
<name sortKey="Ouattara, Bazoumana" sort="Ouattara, Bazoumana" uniqKey="Ouattara B" first="Bazoumana" last="Ouattara">Bazoumana Ouattara</name>
<name sortKey="Samadi, Pershia" sort="Samadi, Pershia" uniqKey="Samadi P" first="Pershia" last="Samadi">Pershia Samadi</name>
<name sortKey="Samadi, Pershia" sort="Samadi, Pershia" uniqKey="Samadi P" first="Pershia" last="Samadi">Pershia Samadi</name>
</country>
<country name="Suisse">
<noRegion>
<name sortKey="Gasparini, Fabrizio" sort="Gasparini, Fabrizio" uniqKey="Gasparini F" first="Fabrizio" last="Gasparini">Fabrizio Gasparini</name>
</noRegion>
<name sortKey="Gomez Mancilla, Baltazar" sort="Gomez Mancilla, Baltazar" uniqKey="Gomez Mancilla B" first="Baltazar" last="Gomez-Mancilla">Baltazar Gomez-Mancilla</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D20 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001D20 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:10-0234566
   |texte=   Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022